Sign in
4

Changes in Ownership

OCULAR THERAPEUTIX, INC Filed Acc 0001104659-26-101674

Chief Development Officer sold 3,035 shares at $10.77 ($32,687)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Kaiser Peter · Chief Development Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-08-24 Sale : show line 1 in the form 10b5-1 −3,035 $10.77 $32,687 264,378 D
Open-market sales · 3,035 sh · avg $10.77 · $32,687
Loading xslF345X06/tm2624096-4_4seq1.xml…